CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 10 enrolled
Drug / intervention
Fludeoxyglucose PET CT +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03262389
NCT03262389Phase 2Completed
CompareCT.gov

Comparison of F-18 FDG PET CT and PET MRI With C-11 Acetate PET CT and PET MRI in the Diagnosis of Active Multiple Myeloma Disease: a Pilot Study

Michael C Roarke, MD·interventional·Posted Aug 25, 2017·Updated Mar 16, 2021

In Brief

A Phase 2 clinical trial evaluating Fludeoxyglucose PET CT, Sodium Acetate C11 PET CT, and 2 other interventions for Multiple Myeloma. Completed, enrolled 10 participants across 1 site.

Detailed Summary

Investigators are doing this study to determine which of four imaging techniques: Fludeoxyglucose Positron Emission Tomography (18 FDG PET) computerized tomography (CT), 18 FDG PET Magnetic resonance imaging (MRI), C-11 acetate PET CT, and C-11 acetate PET MRI) is the best test for finding sites of active myeloma disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Myeloma
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedAug 25, 2017
Enrollment StartSep 19, 2017
Primary CompletionNov 23, 2019
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 8.9 years ago

Interventions

Fludeoxyglucose PET CTdrug

Route of administration is intravenous. Dose of each injection will be the standard 5 to 10 millicurie (mCi).

Sodium Acetate C11 PET CTdrug

Route of administration is intravenous. Dose of each injection will be 10 mCi (370 MBq).

Fludeoxyglucose PET MRIdrug

Route of administration is intravenous. Dose of each injection will be the standard 5 to 10 millicurie (mCi).

Sodium Acetate C11 PET MRIdrug

Route of administration is intravenous. Dose of each injection will be 10 mCi (370 MBq).